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Abstract. Background. Breast cancer is one of the most diagnosed cancer in the world. 
Breast cancer starts when the breast cell grows abnormally and turns malignant. In 
Indonesia, breast cancer is the most diagnosed cancer in women. Up to now, the cause of 
breast cancer has not been identified yet. There are many factors that increase the risk of 
breast cancer, one of them is the early age of menarche. Objective. This study aim was to 
obtain characteristics of breast cancer patients based on age of menarche in RSUP Haji 
Adam Malik over 2014 -2017. Method. The study designed is observational with 
descriptive method. We used total sampling technique to get sampels. Results. Based on 
general characteristics, the majority of breast cancer patients are in the range of 40-49 years 
old (38,5%), graduated high school (45,2%), unemployed (66,3%), and do not have family 
history (94,2%). Majority of patients have stadium IIIB breast cancer (41,3%). The most 
diagnosed histopathology is Invasive Ductal Carcinoma (78,8%). Majority of breast cancer 
patients have negative estrogen receptor (67,3%), negative progesterone receptor (67,3%), 
negative her2 (66,3%) and positive ki-67 (67,3%). Fifty three breast cancer patients (51%) 
have early menarche. Based on the age of menarche, the patient with early menarche 
mostly has stage three breast cancer, but the age of menarche does not give a specific 
characteristic in histopathology and immunohistochemistry. Conclusion. Age of menarche 
gives specific characteristic in staging but not in histopathology and 
immunohistochemistry. 
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1 Introduction 
Breast cancer is the most diagnosed cancer in woman. It is the most common new cases cancer 
in the world, second only to lung cancer. (1) In 2018, there were estimated 2.1 million brast 
cancer cases among women in the world and aproximately 627.000 women died from breast 
cancer (2). Breast cancer is one out of four cancer that caused the deatth of women in the world, 
(3) In Indonesia, breast cancer has the highest prevalence in women with 42,1 cases per 100.000 
citizen and estimation of 17 death per 100.000 patients. (4) The etiology of breast cancer is still 
unclear,but studies has shown that the risk of breast cancer is combination of factors such as age 
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above 55 years old, obesity, smoking, genetic factor, and hormonal factor. (5) The hormonal 
factor is related to estrogen hormone. This hormone is responsible for the development and 
regulation of female reproductive system. This hormone can also act as the promotor of breast 
cancer. (6) One of the hormonal risk cancer is the age of menarche. Even though the age of 
menarche is one of the well-established factor of breast cancer, some study has shown that there 
are no significant relation between them. (7). In this study we try to find out the evidence of 
breast cancer with menarche.  
2 Methods  
This study was an observational descriptive study with cross-sectional methods. We collected   
secondary data from medical records. Data were collected at Haji Adam Malik General Hospital 
Medan. The population in this study is hospitalized breast cancer patients from January 2014- 
December 2017. The samples that were included in this study are breast cancer patient with 
confirmed histopathology examination and has complete data in characteristics that are needed 
in this study, such as age of menarche, staging, histopathology and immunohistochemistry . All 
collected data were performed in distributive frequency tables.. 
3 Results 
From January 2014 untill December 2017 periode, there are 1222 hospitalized breast cancer 
patients. Among 1222 patients, there are only 104 patients who are suitable in the criteria of this 
study. General characteristic of Brest Cancer Patients can be seen at table 1 
Table 1. Distribution of  General Characteristic of Breast Cancer Patients 
Characteristic Frequency Percentage 
Gender   
Female 104 100% 
Male 0 0% 
Age   
<30 0 0% 
30-39 8 7,7% 
40-49 40 38,5% 
50-59 35 33,7% 
60-69 17 16,3% 
70-79 4 3,8% 
>80 0 0% 
Education   
Primary School 24 23,1% 
Junior high school 14 13,5% 
Senior high school 47 45,2% 
University 19 18,3% 
Occupation   




Farmer 6 5,8% 
Businessman 4 3,8% 
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Family History 
Yes 6 5,8% 
No 98 94,2% 
 
From the table above, we found that there was no male who got breast cancer in this study. 
Prevalence of breast cancer mostly over 40 years old, and 94,2% of them didn’t have family 
history.  
Table 2. Sample Distribution of Breast Cancer Patients Based on Menarche 
Characteristic Freruency by Age of Menarche (years) 
 ≤12 % 13-15 % >15 % 
Total Case 53  (51%) 47  45,2% 4  3,8% 
Staging 
0 0 (0%) 0 (0%) 0 (0%) 
IA 0 (0%) 0 (0%) 0 (0%) 
IB 1 (1,9%) 0 (0%) 0 (0%) 
IIA 0 (0%) 1 (2,1%) 0 (0%) 
IIB 5 (9,4%) 11 (23,%) 0 (0%) 
IIIA 5 (9,4%) 2 (4,2%) 0 (0%) 
IIIB 22 (41,5%) 18 (38,3%) 3 (75%) 
IIIC 1 (1,9%) 2 (4,2%) 0 (0%) 
IV 19 (35,8%) 13 (27,7%) 1 (25%) 
Histopathology 
Ductal Carcinoma In Situ 1 (1,9%) 0 (0%) 0 (0%) 
Invasive Breast Carcinoma 
No Special Type 
4 (7,5%) 7 (14,9%) 1 (25%) 
Invasive Ductal Carcinoma 45 (84,9%) 34 (72,3%) 3 (75%) 
Invasive Lobular 
Carcinoma 
3 (5,6%) 3 (6,4%) 0 (0%) 
Mucinous Carcinoma 0 (0%) 1 (2,1%) 0 (0%) 
Tubular Carcinoma 0 (0%) 2 (4,3%) 0 (0%) 
Estrogen Receptor       
Positive 19 (35,8%) 13 (27,7%) 2 (50%) 
Negative 34 (64,2%) 34 (72,3%) 2 (50%) 
Progesterone Receptor 
Positive 25 (47,2%) 10 (21,3%) 1 (25%) 
Negative 28 (52,8%) 37 (78,7%) 3 (75%) 
HER2 
1 Positive 37 (69,8%) 29 (61,7%) 2 (50%) 
2 Positive 0 (0%) 1 (2,1%) 0 (0%) 
3 Positive 16 (30,2%) 17 (36,2%) 2 (50%) 
Ki-67 
Positive 28 (52,8%) 28 (59,6%) 2 (50%) 
Negative 25 (47,2%) 19 (40,4%) 2 (50%) 
From the data above, we found that breast cancer mostly happened in earlier menarche (≤12 
years), with histopatholgical type is invasive ductal carcinoma.  
4 Discussion 
In this study, the breast cancer patients in Haji Adam Malik General Hospital is 100% female 
which is correspondent with Global Cancer Observatory data.(8) Even though all of the breast 
cancer patients are female, it does not mean that male cannot be at risk of breast cancer. In 
2019, American Cancer Society estimated  about 2670 new cases of male breast cancer and  
approximately up to 500 male die because of breast cancer in America. (9) The breast cancer 
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patints in this study is 30-79 years old. Most of the patients are in the range of 40-49 years old. 
This result is simmilar with breast cancer profile in Manado. (10) But this result does not go 
along with the surveilance study in America which says the incidence of breast cancer will 
inceased along with the age. (11) Majority of the breast cancer patients in this study are 
graduated from high school. This result  is simmilar to breast cancer profile in Manado where 
61% of the breast cancer patients are graduated from high school. (10) This result also go along 
with the demography data of Neighborhood and Breast Cancer (NABC) where the breast cancer 
patient has finished post secondary. (12) The majority of breast cancer patient in Haji Adam 
Malik General Hospital is unemployed. This result goes along with the study by Dewi and 
Hendrati (13) but not with the study by Fenga which say that mstly breast cancer paient is 
employed and have work night shifed and their occupation is increasing the risk of breast 
cancer. (14) Even though that family history is one of the well established risk factor in breast 
cancer, only six patients in this study has family history and the rest 94,2% do not have any 
family history (94,2%). (5) 
From table 4.2, we can see that 53 patients have early age of menache (≤12 years old), 47 
patients with age of menarche between 13-15 yearls old and 4 patients with late menarche (> 15 
years old). Majority of the breast cancer patient in Haji Adam Malik General Hospital has an 
early age of menarche which is the risk factor of breast cancer. (5) Early age of menarche make 
an individual has longer time interacted with estrogen which proliferate the breast cells and also 
produce metabolites which can lead to breast cancer by mutation.  
In staging, the majority of breast cancer is in stage III B. Based on the study by Qoyyimah and 
Yuliyani, the patient with early age of menarche mostly is in stage III  which is simillar to this 
study. (14) But it is different with the study by Aini which says the most patient in early age of 
menarche is in stage IV (60,4%). (15) In histopathology, in all group of menarche invasive 
ductal carcinoma (IDC) is mostly diagnosed. This result does not go along wih the study in 
2012 by Collaborative Group on Hormonal Factors in Breast Cancer in which invasive lobular 
carcinoma (ILC) is mosly found, but this result is simillar to Chen in 2017 which says the most 
diagnosed and found in breast cancer patient is invasive ductal carcinoma.  
In immunochemistry, age of menarche does not give a specific characteristic as mostly the 
result is the same in every group. By estrogen receptor, most patient in Haji Adam Malik 
General Hospital has negative result. The study by Ambrosone says that the risk of breast cancer 
with ER-negative will decrease in the later of menarche. (18) But this result does not fo along 
with the patient in Adam Malik as the percentage of ER-negative breast cancer increase in the 
later group of menarche age. In progesterone receptor, HER-2 and Ki-67, there is no study 
which link them with the age of menarche. In this study, mostly breast cancer patient has 
negative receptor progesterone, negative Her2 and positive Ki-67 in all group of menarche age.  
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5 Conclusion 
The breast cancer patients in Haji Adam Malik General Hospital are mostly in the range age of 
40-49 years old, finished high school, unemployed, have no famly history. Generally, the breast 
cancer patients are on stage III B (41,3%), with invasive ducal carcinoma finding (78,8%), 
negative estrogen receptor (67,3%), negative progesterone receptor (65,4%), negative her2 
(66,3%) and positive ki-67 (55,7%). Majority of the breast cancer patients have early age of 
menarche (≤12 years old). The age of menarche doesnot give specific charcteristic finding in 
staging, histopathology and immunohistochemistry  
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